ArticleJournal of hepatocellular carcinoma2025

Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Donafenib and Camrelizumab in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Retrospective, Single-Arm Study.

Chenrui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.